Rota-090
Research payments
$334,486
Through program year 2020, $334,486 in research payments was reported against Rota-090, across 72 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $73,077 | 6 |
| 2019 | Research | $261,409 | 66 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Beth Manning Cleveland, OH Named on 8 payments
- Luke Anschutz Lincoln, NE Named on 4 payments
- Alan Garscadden Lakewood, CO Named on 4 payments
- Nicola Klein Campbell, CA Named on 3 payments
- Khozema Palanpurwala Conroe, TX Named on 3 payments
- Keith Pulvermacher Marshfield, WI Named on 3 payments
- Paul Bernhardson Lincoln, NE Named on 3 payments
- Alvin Gabrielsen Layton, UT Named on 2 payments
- Joseph Domachowske Syracuse, NY Named on 2 payments
- Anthony Pruitt Ogden, UT Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.